Company developing drugs that treats degenerative diseases
Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. Through the controlled activation of progenitor cells, Frequency enables disease modification without the complexity of genetic engineering. Our lead program re-creates sensory cells in the inner ear to treat chronic noise induced hearing loss, which affects over 30 million people in the U.S. alone.
Visit website: https://www.frequencytx.com/
People at Frequency Therapeutics
Frequency Therapeutics News
Longevity Technology interviews Frequency Tx' CSO about activating innate progenitor cells
Longevity Technology - 01-Nov-2022
Cells are already in the right place, just need the right kick to help repair the body when neededRead more...
Hearing loss drug triggers improvements in phase 1/2 trials
FierceBiotech - 09-Apr-2019
Restoring hearing and vision would make many people's lives significantly easierRead more...